C21 Investments Inc. (CXXI.CN)
| Previous Close | 0.3000 |
| Open | 0.3150 |
| Bid | 0.3250 x 0 |
| Ask | 0.3500 x 0 |
| Day's Range | 0.3150 - 0.3500 |
| 52 Week Range | 0.2650 - 0.6400 |
| Volume | |
| Avg. Volume | 28,795 |
| Market Cap | 42.017M |
| Beta (5Y Monthly) | 2.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileC21 Investments Announces Q2 Earnings Date and Provides Operational Update
New Dispensary Generating Strong Sales Growth during the Quarter Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its second quarter financial results for the period ended September 30, 2024. The Company is also taking the opportunity to provide an operational update for the period. All currency is reported in U.S. d
CNW GroupC21 Investments Reports First Quarter Results
C21 Investments Inc. (CSE: CXXI) and (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced the filing of its unaudited financial statements and management discussion and analysis for its first quarter ending June 30, 2024, on SEDAR. The Company's financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP"). All currency is reported in U.S. dollars. The Company recently changed its fiscal reporting period
